Background: Hospital surfaces are considered important vectors in the spread of nosocomial pathogens. This study evaluated microbial counts on novel antimicrobial bedrail covers over a 2-week period in a critical care environment. Methods: Disposable bedrail covers (Aionx Inc, Hershey, PA) made of a copper and silver polymer and capable of conducting an imperceptible surface potential, were installed in a case-control manner on a series of occupied intensive care unit beds. Seventeen bedrails were covered with the study bedrail surface, and 17 were left uncovered. Two hundred seventy-two microbial surface cultures were obtained from both study and control bedrails and analyzed for microbial growth by bacterial enumeration and speciation. Results: The bedrails covered with the study surface demonstrated >80% average decrease in colony forming units across the study period of 15 days. Conclusions: These novel, detachable bedrail covers successfully demonstrated significant bacterial count reduction in an intensive care unit setting. This may have implications for acquisition of hospitalacquired infections.
In the United States, 4.5% of hospitalized patients develop health care-associated infections (HAIs), resulting in an estimated 100,000 deaths. 1 To prevent HAIs, infection prevention and control (IPC) guidelines recommend that, in conjunction with hand hygiene, attention be paid to disinfection of patient-care surfaces, especially those designated as high-touch objects. 2 Disinfection of these surfaces by hospital-grade chemicals is episodic and has limited residual activity. In contrast, antimicrobial surfaces provide continuous antisepsis with prolonged residual effects. 3 Metallic copper and silver have intrinsic broad-spectrum antimicrobial activity, and copper bedrails have specifically been shown to reduce bacterial burden in intensive care unit (ICU) settings. 4 The technology studied here amplifies this effect by releasing a subclinical electric potential through a proprietary polymer (Aionx Inc, Hershey, PA). We carried out this study to confirm and quantify this antibacterial efficacy in a high-risk acute care setting.
METHODS
This study was approved by our institutional review board and was conducted in a prospective, randomized controlled manner in the medical-surgical intensive care unit of Geisinger Medical Center. Geisinger Medical Center is a 550-bed tertiary care academic hospital with 42 adult ICU beds. The ICUs are located on 2 floors (fourth and fifth) with 5 separate "pods": 2 pods on 1 floor, 3 on the other. In total, 4 pods were used in this study (2 on each floor). On the fourth floor, each pod contained 9 beds, whereas on the fifth floor, each pod contained 8 beds. Both floor units housed 1 study group (bedrails with the antimicrobial cover) and 1 control group (bedrails with no cover). This provided 34 total beds, 17 in each arm of the study. The bedrails (model P3200 bed; Hill-Rom, Chicago, IL) were made of standard, mildly textured polypropylene. The study bedrail cover was applied to the bedrail closest to the patient's head (Fig 1) . The study was run between May 9, 2016, and May 24, 2016.
After initiation of the study and application of the bedrail covers, microbial samples were obtained by utilizing CultureSwab EZ sterile swabs (Becton Dickson, Franklin Lakes, NJ). To obtain a culture, the swab was carefully rolled across the entire surface of the bedrail and underbelly (approximately 90 in). Coded specimens were transported to a microbiology laboratory at the Pennsylvania State University, where 1 mL sterile saline was added to each swab and vortexed for 10 seconds. A sample of 100 μL solution was then pipetted onto a blood agar plate (tryptic soy agar with 5% sheep blood; Remel Inc, Lenexa, KS). The remaining solution was used to make a serial dilution of 1:10 and 1:100. From these 2 dilutions, 100 μL was pipetted onto a separate blood agar plate, generating a total of 3 blood agar plates per swab. The plates were then incubated for 24-48 hours at 37°C.
After incubation, colonies were counted on each plated and recorded as colony forming units per milliliter. Also, at least 2 unique morphologies were subcultured on blood agar for another 24-48 hours (37°C) and identified using matrix-assisted laser desorption ionization-time of flight mass spectrometry in standard fashion (MALDI-TOF MS and MALDI Biotyper 2.0 software, Bruker Daltonics, Bremen, Germany). Samples were obtained on days 0, 1, 2, 3, 4, 5, 10, and 15.
During this study, no additional infection control or cleaning procedures were introduced; daily cleaning, discharge cleaning, and terminal cleaning procedures were performed per standard institutional protocols. There were no specific outbreaks. Hand hygiene compliance continued to be monitored using a product-consumption mathematical model per institutional standards. 5 Patient-days, patient-hours, average length of stay, number of patients, and nurseto-patient ratio was assessed for both groups. Overall case-mix index of disease severity (CMI) was monitored.
RESULTS
The study bedrail group and control groups were comparable in patient-days (269 study vs 262 control), patient-hours (6,453 study vs 6284 control), average length of stay (4.6 days study vs 4.1 days control), overall number of patients in each group (58 study vs 64 control), and nurse-to-patient ratio (1.7 study vs 1.8 control). CMI was unchanged from baseline over the study period, as was hand hygiene compliance (>99%).
A summary of total bacterial colony forming units per milliliter and colony forming units per milliliter per bed was analyzed between both groups (Tables 1 and 2 ). With the exception of a single day (day 3), each day sampled showed a significant reduction in colony growth with overall 82.5% reduction in the total colony forming units per milliliter (P < .001), and an 80% reduction in colony forming units per milliliter per bed (P < .001). Closer review of the culture data from day 3 indicated that a single swab taken from a single room represented more than 54% of the microbial burden seen on the experimental surfaces that day (1,400 CFU for bed 3 vs 2,570 CFU/mL daily total for all other beds combined, indicating a clear outlier in the dataset. For the first 10 days the decrease in colony forming units per milliliter ranged from 79.3%-94.2%. Day 15 showed a diminished antimicrobial effect (52.3% reduction in colony forming units per millliter as compared with control bed rails on that same day).
Additionally, data were subdivided into 3 groups: 0 CFU/mL, <50 CFU/mL, and <100 CFU/mL. The study bedrail group exhibited higher microbial inhibition compared with the control surface in each grouping, with the study bedrail group demonstrating no growth (0 CFU/mL) in 28% of samples compared with only 6% of the control surfaces.
The most notable nosocomial pathogens isolated from the tested surfaces were Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Enterococcus faecalis, Enterococcus faecium, Moraxella species, and Pseudomonas species. The combined tally of colony forming units for these nosocomial pathogens was also significantly lower for the study group compared with the control group (P value < .001).
DISCUSSION
Hospital surfaces are known to be vectors for the transmission of pathogens through contact with the hands of health care workers, and surfaces nearest the patient, such as bedrails, have been shown to contaminate the hands of health care workers similar to that of direct patient contact. 6, 7 Moreover, patients admitted to a room after the discharge of a patient colonized with a drug-resistant pathogen are more likely to acquire that pathogen despite terminal room cleaning. [8] [9] [10] Bacteria responsible for nosocomial infections are known to survive days, weeks, or even months on these hospital surfaces. Some argue that cleaning must lower the bacterial burden to levels unmanageable by standard practices (<250 CFU/100 cm). 11 This has prompted exploration of surfaces that have antiseptic properties. 3 Several studies have demonstrated that these surfaces reduce the microbiologic burden below that of terminal room cleaning, and the effect is continuous rather than episodic. 12, 13 Copper and silver substrates have demonstrated these properties, but widespread adaptation to environment surfaces is limited by cost and practicality.
14-18 Herein, we report efficacy of a proprietary silver-copper polymer charged by a small surface battery that enhances ion release for increased bacterial toxicity. This was adapted to cover a patient bedrail in a disposable fashion, and produced more than an 80% decrease in bacterial burden compared with control bedrails.
There are several limitations to our study. Although severity of illness (ie, CMI) was stable throughout the study period, and patients were randomly placed either in a room with a study bedrail or a control room, the specific CMI for each cohort was not analyzed. We believe significant differences in illness severity are unlikely given that the ICU was full to capacity, the CMI was consistently high overall, and all beds were used for the same type of patient.
Another potential limitation is that the study was not blinded to the hospital staff because the study bedrail cover was visually apparent. The probability that this produced differences in nursing behavior given the criticality of the patients seemed remote; if anything, staff could be more likely to touch a bedrail that is perceived to be cleaner.
This study cannot prove that decreases in bacterial burden of a bedrail will result in decreases in nosocomial infections. Further studies are needed to assess clinical outcomes. That said, this is the first disposable bedrail cover to demonstrate statistically significant decreases in bacterial contamination in a high acuity patient care setting. Furthermore, this technology functionally has the potential to be adapted to other environment surfaces, thus carrying larger clinical and even public health implications.
